Biomarkers in coronary artery disease: systematic review and meta-analysis.

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Future cardiology Pub Date : 2025-01-01 Epub Date: 2025-01-15 DOI:10.1080/14796678.2024.2442214
Nicola King, Neil A Smart, Theodore Bungon, Martin Peacock, Shakil A Awan
{"title":"Biomarkers in coronary artery disease: systematic review and meta-analysis.","authors":"Nicola King, Neil A Smart, Theodore Bungon, Martin Peacock, Shakil A Awan","doi":"10.1080/14796678.2024.2442214","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Little information exists regarding the detection of early coronary heart disease protein biomarkers. The aim of this study was to investigate several potential candidates.</p><p><strong>Methods: </strong>Systematic review was carried out followed by meta-analysis.</p><p><strong>Results: </strong>The standardized mean difference (95% confidence intervals) for each comparison was: Troponins 2.31 (1.18, 3.4), iL-6 1.3 (0.8, 1.81), fibrinogen 1.55 (1.16, 1.94), NT-proBNP 1.05 (0.72, 1.38), lipoprotein a 0.75 (0.48, 1.03) osteoprotegerin 0.92 (0.23, 1.62), VCAM-1 1.53 (0.87, 2.18), pentraxin 3 0.87 (-0.13, 1.87), PAI-1 2.51 (-0.65, 5.66) MMP9 1.25 (0.36, 2.14), MCP-1 1.99 (1.12, 2.85) and adiponectin -1.11 (-1.49, -0.73).</p><p><strong>Conclusion: </strong>Multiple biomarkers that could potentially be used for the early detection of coronary heart disease were identified.</p>","PeriodicalId":12589,"journal":{"name":"Future cardiology","volume":" ","pages":"39-46"},"PeriodicalIF":1.6000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11812396/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/14796678.2024.2442214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Little information exists regarding the detection of early coronary heart disease protein biomarkers. The aim of this study was to investigate several potential candidates.

Methods: Systematic review was carried out followed by meta-analysis.

Results: The standardized mean difference (95% confidence intervals) for each comparison was: Troponins 2.31 (1.18, 3.4), iL-6 1.3 (0.8, 1.81), fibrinogen 1.55 (1.16, 1.94), NT-proBNP 1.05 (0.72, 1.38), lipoprotein a 0.75 (0.48, 1.03) osteoprotegerin 0.92 (0.23, 1.62), VCAM-1 1.53 (0.87, 2.18), pentraxin 3 0.87 (-0.13, 1.87), PAI-1 2.51 (-0.65, 5.66) MMP9 1.25 (0.36, 2.14), MCP-1 1.99 (1.12, 2.85) and adiponectin -1.11 (-1.49, -0.73).

Conclusion: Multiple biomarkers that could potentially be used for the early detection of coronary heart disease were identified.

冠状动脉疾病的生物标志物:系统回顾和荟萃分析。
关于早期冠心病蛋白生物标志物的检测信息很少。本研究的目的是调查几种潜在的候选药物。方法:采用系统评价和meta分析。结果:各比较的标准化平均差异(95%置信区间)为:肌钙蛋白2.31(1.18,3.4)、iL-6 1.3(0.8, 1.81)、纤维蛋白原1.55(1.16,1.94)、NT-proBNP 1.05(0.72, 1.38)、脂蛋白a 0.75(0.48, 1.03)、骨保护蛋白0.92(0.23,1.62)、VCAM-1 1.53(0.87, 2.18)、pentraxin 3 0.87(-0.13, 1.87)、PAI-1 2.51(-0.65, 5.66)、MMP9 1.25(0.36, 2.14)、MCP-1 1.99(1.12, 2.85)、脂联素-1.11(-1.49,-0.73)。结论:发现了多种可能用于冠心病早期检测的生物标志物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Future cardiology
Future cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.80
自引率
5.90%
发文量
87
期刊介绍: Research advances have contributed to improved outcomes across all specialties, but the rate of advancement in cardiology has been exceptional. Concurrently, the population of patients with cardiac conditions continues to grow and greater public awareness has increased patients" expectations of new drugs and devices. Future Cardiology (ISSN 1479-6678) reflects this new era of cardiology and highlights the new molecular approach to advancing cardiovascular therapy. Coverage will also reflect the major technological advances in bioengineering in cardiology in terms of advanced and robust devices, miniaturization, imaging, system modeling and information management issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信